RT Journal Article
SR Electronic
T1 COVID-19 Spreading Dynamics with Vaccination – Allocation Strategy, Return to Normalcy and Vaccine Hesitancy
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.10.20247049
DO 10.1101/2020.12.10.20247049
A1 Shayak, B
A1 Sharma, Mohit M
YR 2020
UL http://medrxiv.org/content/early/2020/12/11/2020.12.10.20247049.abstract
AB In this work we use mathematical modeling to analyse the dynamics of COVID-19 spread after a vaccination program is initiated. The model used is a delay differential equation developed earlier by our group. Basis of currently available data, our principal findings are as follows. (a) For fastest deceleration of the pandemic, people with high interaction rate such as grocers and airline cabin crew should be given priority in vaccine access. (b) Individuals who have been vaccinated may be selectively cleared to return to normal activities without significant risk of a resurgence in cases. (c) If an infection as well as a vaccine confers immunity for a duration τ0, then the pandemic can be eliminated by vaccinating people at a sufficiently high rate. Unless τ0 is very small, the cutoff rate required appears feasible to achieve in practice. (d) The presence of a substantial minority of vaccine-hesitant population might not amount to a significant threat or even an inconvenience to a vaccine-compliant majority population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe have not received any funding for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval required for mathematical modeling study..All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe manuscript does not use any data.